Mongaya, Rio D.
HRN: 21-16-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/20/2024
01/27/2024
IV
650mg
Q6
Tc Fournier's Gangrene
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes